Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuchong Yang

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
BMC Cancer|May 10, 2023
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancerYuchong Yang, Yao Lu, Hui Tan, et al.
Theranostics|July 30, 2020
Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axisHaiou Yang, Haiyang Zhang, Yuchong Yang, et al.
Theranostics|April 11, 2022
Erratum: Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis: ErratumHaiou Yang, Haiyang Zhang, Yuchong Yang, et al.
Theranostics|June 10, 2024
Erratum: Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis: ErratumHaiou Yang, Haiyang Zhang, Yuchong Yang, et al.
Molecular Oncology|July 2, 2021
iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidationDan Lin, Haiyang Zhang, Rui Liu, et al.
BMC Cancer|March 5, 2023
Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trialLe Zhang, Weixue Wang, Shaohua Ge, et al.
BMC Cancer|February 23, 2024
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinomaYuchong Yang, Hui Tan, Yao Lu, et al.
BMC Cancer|March 5, 2024
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort studyJingjing Duan, Lila Zhu, Yinghui Shi, et al.
Molecular Cancer|February 29, 2020
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancerHaiyang Zhang, Ting Deng, Rui Liu, et al.
Eclinicalmedicine|November 12, 2021
Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trialLikun Zhou, Rui Liu, Dingzhi Huang, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
BMC Cancer|May 10, 2023
The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancerYuchong Yang, Yao Lu, Hui Tan, et al.
Theranostics|July 30, 2020
Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axisHaiou Yang, Haiyang Zhang, Yuchong Yang, et al.
Theranostics|April 11, 2022
Erratum: Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis: ErratumHaiou Yang, Haiyang Zhang, Yuchong Yang, et al.
Theranostics|June 10, 2024
Erratum: Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis: ErratumHaiou Yang, Haiyang Zhang, Yuchong Yang, et al.
Molecular Oncology|July 2, 2021
iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidationDan Lin, Haiyang Zhang, Rui Liu, et al.
BMC Cancer|March 5, 2023
Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trialLe Zhang, Weixue Wang, Shaohua Ge, et al.
BMC Cancer|February 23, 2024
Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinomaYuchong Yang, Hui Tan, Yao Lu, et al.
BMC Cancer|March 5, 2024
Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort studyJingjing Duan, Lila Zhu, Yinghui Shi, et al.
Molecular Cancer|February 29, 2020
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancerHaiyang Zhang, Ting Deng, Rui Liu, et al.
Eclinicalmedicine|November 12, 2021
Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trialLikun Zhou, Rui Liu, Dingzhi Huang, et al.
Pageof 6